105 related articles for article (PubMed ID: 11790126)
1. Aggregation of beta(2)-glycoprotein I induced by sodium lauryl sulfate and lysophospholipids.
Hagihara Y; Hong DP; Hoshino M; Enjyoji K; Kato H; Goto Y
Biochemistry; 2002 Jan; 41(3):1020-6. PubMed ID: 11790126
[TBL] [Abstract][Full Text] [Related]
2. Flexible loop of beta 2-glycoprotein I domain V specifically interacts with hydrophobic ligands.
Hong DP; Hagihara Y; Kato H; Goto Y
Biochemistry; 2001 Jul; 40(27):8092-100. PubMed ID: 11434778
[TBL] [Abstract][Full Text] [Related]
3. Identification of the phospholipid-binding site of human beta(2)-glycoprotein I domain V by heteronuclear magnetic resonance.
Hoshino M; Hagihara Y; Nishii I; Yamazaki T; Kato H; Goto Y
J Mol Biol; 2000 Dec; 304(5):927-39. PubMed ID: 11124037
[TBL] [Abstract][Full Text] [Related]
4. The binding site in {beta}2-glycoprotein I for ApoER2' on platelets is located in domain V.
van Lummel M; Pennings MT; Derksen RH; Urbanus RT; Lutters BC; Kaldenhoven N; de Groot PG
J Biol Chem; 2005 Nov; 280(44):36729-36. PubMed ID: 16091370
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome.
Schwarzenbacher R; Zeth K; Diederichs K; Gries A; Kostner GM; Laggner P; Prassl R
EMBO J; 1999 Nov; 18(22):6228-39. PubMed ID: 10562535
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of the interaction of beta(2)-glycoprotein I with negatively charged phospholipid membranes.
Hammel M; Schwarzenbacher R; Gries A; Kostner GM; Laggner P; Prassl R
Biochemistry; 2001 Nov; 40(47):14173-81. PubMed ID: 11714270
[TBL] [Abstract][Full Text] [Related]
7. Structure and function of the recombinant fifth domain of human beta 2-glycoprotein I: effects of specific cleavage between Lys77 and Thr78.
Hagihara Y; Enjyoji K; Omasa T; Katakura Y; Suga K; Igarashi M; Matsuura E; Kato H; Yoshimura T; Goto Y
J Biochem; 1997 Jan; 121(1):128-37. PubMed ID: 9058203
[TBL] [Abstract][Full Text] [Related]
8. Role of the N- and C-terminal domains of bovine beta 2-glycoprotein I in its interaction with cardiolipin.
Hagihara Y; Goto Y; Kato H; Yoshimura T
J Biochem; 1995 Jul; 118(1):129-36. PubMed ID: 8537301
[TBL] [Abstract][Full Text] [Related]
9. The interaction of β
Sato A; Nakazawa K; Sugawara A; Yamazaki Y; Ebina K
Biochim Biophys Acta Proteins Proteom; 2018 Dec; 1866(12):1232-1241. PubMed ID: 30312773
[TBL] [Abstract][Full Text] [Related]
10. Ellagic acid/phospholipid-induced coagulation and dextran sulfate-induced fibrinolytic activities in beta 2-glycoprotein I-depleted plasma.
Shiozaki A; Niiya K; Higuchi F; Tashiro S; Arai T; Izumi R; Sakuragawa N
Thromb Res; 1994 Oct; 76(2):199-210. PubMed ID: 7863469
[TBL] [Abstract][Full Text] [Related]
11. The fifth domain of beta 2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies.
Hunt J; Krilis S
J Immunol; 1994 Jan; 152(2):653-9. PubMed ID: 7506730
[TBL] [Abstract][Full Text] [Related]
12. Recombinant domain V of β2-glycoprotein I inhibits the formation of a 7-ketocholesteryl-9-carboxynonanoate and β2-glycoprotein I complex.
Zhang Y; Li W; Chi Y; Wang R; Wang D; Zhang F; Liu Z; Matsuura E; Liu Q
J Biochem; 2011 Jan; 149(1):35-42. PubMed ID: 20876187
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of phospholipid binding by the C2A-domain of synaptotagmin I.
Zhang X; Rizo J; Südhof TC
Biochemistry; 1998 Sep; 37(36):12395-403. PubMed ID: 9730811
[TBL] [Abstract][Full Text] [Related]
14. High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II.
Ma K; Simantov R; Zhang JC; Silverstein R; Hajjar KA; McCrae KR
J Biol Chem; 2000 May; 275(20):15541-8. PubMed ID: 10809787
[TBL] [Abstract][Full Text] [Related]
15. The interaction of beta(2)-glycoprotein I domain V with chaperonin GroEL: the similarity with the domain V and membrane interaction.
Gozu M; Hoshino M; Higurashi T; Kato H; Goto Y
Protein Sci; 2002 Dec; 11(12):2792-803. PubMed ID: 12441378
[TBL] [Abstract][Full Text] [Related]
16. Human beta 2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-beta 2-glycoprotein I antibodies.
Del Papa N; Sheng YH; Raschi E; Kandiah DA; Tincani A; Khamashta MA; Atsumi T; Hughes GR; Ichikawa K; Koike T; Balestrieri G; Krilis SA; Meroni PL
J Immunol; 1998 Jun; 160(11):5572-8. PubMed ID: 9605162
[TBL] [Abstract][Full Text] [Related]
17. Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies.
Iverson GM; Reddel S; Victoria EJ; Cockerill KA; Wang YX; Marti-Renom MA; Sali A; Marquis DM; Krilis SA; Linnik MD
J Immunol; 2002 Dec; 169(12):7097-103. PubMed ID: 12471146
[TBL] [Abstract][Full Text] [Related]
18. Proteolytic cleavage of beta(2)-glycoprotein I: reduction of antigenicity and the structural relationship.
Matsuura E; Inagaki J; Kasahara H; Yamamoto D; Atsumi T; Kobayashi K; Kaihara K; Zhao D; Ichikawa K; Tsutsumi A; Yasuda T; Triplett DA; Koike T
Int Immunol; 2000 Aug; 12(8):1183-92. PubMed ID: 10917893
[TBL] [Abstract][Full Text] [Related]
19. Immunization of a rabbit with beta 2-glycoprotein I induces charge-dependent crossreactive antibodies that bind anionic phospholipids and have similar reactivity as autoimmune anti-phospholipid antibodies.
Kouts S; Wang MX; Adelstein S; Krilis SA
J Immunol; 1995 Jul; 155(2):958-66. PubMed ID: 7608571
[TBL] [Abstract][Full Text] [Related]
20. Characterization of beta2-glycoprotein I binding to phospholipid membranes.
Harper MF; Hayes PM; Lentz BR; Roubey RA
Thromb Haemost; 1998 Oct; 80(4):610-4. PubMed ID: 9798980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
